Phase 1 Study of Safety, Tolerability and Pharmacokinetics of SPR994

NCT03395249 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: SPR994
DRUG: Placebo Oral Tablet
DRUG: Orapenem®

Sponsor

Spero Therapeutics

Collaborators

[object Object]